SCHEMBL6621767

SCHEMBL6621767

O=CC(O)c1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2081452 0.78 — —
SCHEMBL22774824 0.74 — —
SCHEMBL4699959 0.74 — —
SCHEMBL1696277 0.74 — —
SCHEMBL4950183 0.74 — —
SCHEMBL7822870 0.74 — —
SCHEMBL31556324 0.74 CYP3A4 (0.44) —
SCHEMBL5104539 0.74 ALOX5 (0.42) —
Hydrochloric Acid SCHEMBL9984331 0.72 IDO1 (0.42) —
SCHEMBL29958333 0.72 ALOX5 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474140-A1 2-OXAZOLAMINES AND THEIR USE AS 5-HT2B RECEPTOR ANTAGONISTS Pharmagene Laboratories Ltd (GB) 2004-11-10 — — EP disclosed
WO-2003068226-A1 2-OXAZOLAMINES AND THEIR USE AS 5-HT2B RECEPTOR ANTAGONISTS PHARMAGENE LABORATORIES LIMITED (GB) 2003-08-21 — — WO disclosed
Send feedback